Dr. Subramaniam is a physician who developed his research interests in clinical pharmacology and neuropharmacology during his postgraduate training at the Postgraduate Institute of Medical Education and Research, Chandigarh, followed by doctoral training at the University of Pennsylvania and postdoctoral training at the National Institute of Neurological Disorders and Stroke. Swami returned to India in 1995 to join Dr Reddy's in their discovery research program. He held varied responsibilities both on the scientific and commercial sides while at Dr Reddy's, including Founder and Managing Director of a subsidiary company, Aurigene. After holding leadership positions at Sanmar Speciality Chemicals and Rheoscience A/S, and at Merck Research Laboratories, he took charge as Head - R&D for Abbott Nutrition in India.In his career he has to his accomplishment the first IND filing of an anticancer drug from Dr Reddy's, several licensing deals, establishment of Dr. Reddy's Pharmaceutical Services business, start-up of India's first drug discovery services venture, establishment and operationalization of Abbott Nutrition's R&D facility in India and multiple strategic business and investment transactions. Dr Subramaniam was a Chevening scholar at the London School of Economics and has attended executive training programs at Stanford Business School, Indian Institute of Management and Indian School of Business.